no image available Dickens & Co. "Hope in the Dark: A Novel Targeted Therapy Shows Promise in Beating Back High-Risk Neuroblastoma" "Scientists Pin Hopes on Ch1418 Antibody as Breakthrough in Relapsed or Refractory Stage 4 Neuroblastoma Patients" Price: 24.00€